Artiva Biotherapeutics, Inc.
ARTVCIK 0001817241 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0028
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Artiva Biotherapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Aslan Fred | OfficerDirector | 9 |
| Bush Jennifer | Officer | 7 |
| Horan Christopher | Officer | 7 |
| Raymon Heather | Officer | 7 |
| Krishnamohan Neha | Officer | 4 |
Showing 1-5 of 36
Page 1 of 8Next
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Artiva Biotherapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Aslan Fred | 4 | 50% | -3.2% | -7.6% | +25.8% | -23.3% |
All filings
59 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|